ELF-3 and TSC-1 as potential markers of recurrence in low-risk non–muscle-invasive bladder cancer

Related articles

1. Circulating tumor DNA concentration at diagnosis is a modifiable prognostic factor for distant metastatic recurrence in patients with high-risk breast cancer receiving neoadjuvant therapy

   This article has 24 authors:

   1. Mark Jesus M. Magbanua
   2. Denise M. Wolf
   3. Christina Yau
   4. Nayelis A. Manon
   5. Rosalyn W. Sayaman
   6. Lamorna Brown Swigart
   7. Gillian Hirst
   8. Wen Li
   9. Claudine Isaacs
   10. Rebecca Shatsky
   11. Amy S. Clark
   12. Alexandra Zimmer
   13. Rita Mukhtar
   14. Amy L. Delson
   15. Jane Perlmutter
   16. Paula R. Pohlmann
   17. Nola M. Hylton
   18. Rita Nanda
   19. Douglas Yee
   20. W. Fraser Symmans
   21. Laura J. Esserman
   22. Hope S. Rugo
   23. Angela DeMichele
   24. Laura J. van ’t Veer

2. Higher Blood-to-Tissue Tumor Mutational Burden Ratio Is Associated With Poorer Overall Survival in Advanced Non-Small Cell Lung Cancer

   This article has 7 authors:

   1. Leeseul Kim
   2. Jongyeop Kim
   3. Jongwoo Kim
   4. Seungah Yoo
   5. Minkyu Shin
   6. Lucas Santana Dos Santos
   7. Young Kwang Chae

3. Evaluation of Urinary Circulating Tumor DNA to Detect Minimal Residual Disease in Patients with High-Risk Non-Muscle Invasive Bladder Cancer

   This article has 24 authors:

   1. Roger Li
   2. Joshua Linscott
   3. Prithvi Murthy
   4. Kyle Rose
   5. Young Pak
   6. Frank Zhang
   7. Yong Huang
   8. G. Daniel Grass
   9. Jonathan Chatzkel
   10. Noah M. Hahn
   11. David J. McConkey
   12. Joshua J. Meeks
   13. Siamak Daneshmand
   14. Thomas W. Flaig
   15. Seth P. Lerner
   16. Logan Zemp
   17. Michael A. Poch
   18. Philippe E. Spiess
   19. Wade J. Sexton
   20. Scott M. Gilbert
   21. Hongzhi Xu
   22. Pan Du
   23. Shidong Jia
   24. Xuefeng Wang